Endocrine therapy in the management of prostatic cancer.
作者信息
Greenberg E
出版信息
Clin Endocrinol Metab. 1980 Jul;9(2):369-81. doi: 10.1016/s0300-595x(80)80039-9.
PMID:6994946
Abstract
摘要
相似文献
1
Endocrine therapy in the management of prostatic cancer.
Clin Endocrinol Metab. 1980 Jul;9(2):369-81. doi: 10.1016/s0300-595x(80)80039-9.
2
[The endocrine profile in prostatic cancer: therapeutic implications].
Actas Urol Esp. 1981 Jan-Feb;5(1):3-12.
3
Hormonal therapy of prostatic cancer.前列腺癌的激素治疗
Cancer. 1980 Apr 15;45(7 Suppl):1929-36.
4
Endocrine manipulation in the treatment of breast cancer.乳腺癌治疗中的内分泌调控
Clin Obstet Gynecol. 1975 Jun;18(2):227-37. doi: 10.1097/00003081-197506000-00015.
5
[Hormone treatment of prostate carcinoma: past achievements and current perspectives].[前列腺癌的激素治疗：过去的成就与当前的展望]
Ned Tijdschr Geneeskd. 1986 Apr 26;130(17):768-71.
6
Treatment of advanced cancer of the prostate.
Semin Surg Oncol. 1985;1(1):38-55. doi: 10.1002/ssu.2980010106.
7
Endocrine therapy of advanced carcinoma of the prostate.晚期前列腺癌的内分泌治疗
Cancer. 1993 Feb 1;71(3 Suppl):1089-97. doi: 10.1002/1097-0142(19930201)71:3+<1089::aid-cncr2820711431>3.0.co;2-h.
8
Carcinoma of the prostate: early endocrine therapy is best.
Semin Urol. 1983 Nov;1(4):269-79.
9
Hormonal aspects of prostatic cancer: a review.前列腺癌的激素方面：综述
J R Soc Med. 1985 Feb;78(2):129-35. doi: 10.1177/014107688507800212.
10
[Hormonal therapy of prostatic carcinoma].[前列腺癌的激素治疗]
Internist (Berl). 1968 Sep;9(9):375-80.
引用本文的文献
1
Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions.超生理剂量睾酮治疗前列腺癌：模型、机制与问题
Cancers (Basel). 2017 Dec 6;9(12):166. doi: 10.3390/cancers9120166.
2
Steroid hormone synthetic pathways in prostate cancer.前列腺癌中的类固醇激素合成途径。
Transl Androl Urol. 2013 Sep;2(3):212-227. doi: 10.3978/j.issn.2223-4683.2013.09.16.
3
Abiraterone in the treatment of metastatic castration-resistant prostate cancer.阿比特龙治疗转移性去势抵抗性前列腺癌
Cancer Manag Res. 2014 Jan 28;6:39-51. doi: 10.2147/CMAR.S39318. eCollection 2014.
4
Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease.去势抵抗性前列腺癌：针对复发性疾病中的雄激素代谢途径
Urol Oncol. 2009 May-Jun;27(3):251-7. doi: 10.1016/j.urolonc.2009.03.016.
Zotero 插件